Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: Addressing the threat of an influenza pandemic

Vaccine

Volumn 29, Issue SUPPL. 1, 2011, Pages

  Surichan, Somchaiya ^a   Wirachwong, Ponthip ^a   Supachaturas, Wutichai ^a   Utid, Kanchala ^a   Theerasurakarn, Sompone ^a   Langsanam, Pimsuk ^a   Lakornrach, Pattharachai ^a   Nitisaporn, Ladda ^a   Chansikkakorn, Chanpen ^a   Vangkanonta, Wilak ^a   Kaweepornpoj, Ruangchai ^a   Poopipatpol, Kittisak ^a   Thirapakpoomanunt, Sit ^a   Srichainak, Somchai ^a   Artavatkun, Witit ^a   Chokevivat, Vichai ^a   Wibulpolprasert, Suwit ^b  

^a Thailand Government Pharmaceutical Organization   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

GPO Thailand; Influenza capacity building; LAIV; Pandemic preparedness

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; PANDEMIC LIVE ATTENUATED INFLUENZA VACCINE; PLACEBO; TRIPLE VACCINE; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG APPROVAL; DRUG MANUFACTURE; DRUG QUALITY; DRUG SAFETY; FEMALE; FOOD AND DRUG ADMINISTRATION; FUNDING; GOOD MANUFACTURING PRACTICE; GOVERNMENT; HEALTH CARE ORGANIZATION; HUMAN; IMMUNOGENICITY; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N2; MOUSE; NONHUMAN; PANDEMIC; PANDEMIC INFLUENZA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGISTRATION; SEASONAL INFLUENZA; THAILAND; VACCINE PRODUCTION; VIRUS SHEDDING; WORLD HEALTH ORGANIZATION; ZYGOTE;

CLINICAL TRIALS AS TOPIC; DRUG APPROVAL; HEALTH POLICY; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS; TECHNOLOGY, PHARMACEUTICAL; THAILAND; WORLD HEALTH ORGANIZATION;

EID: 79959194085     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.04.120     Document Type: Article

References (3)

1. Collin N., de Radiguès X. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 2009, 27:5184-5186.
2. Partridge J., Kieny M. World Health Organization H1N1 influenza vaccine Task Force, Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets. Vaccine 2010 Jul 5, 28(30):4709-4712.
3. Klimov A.I., Kiseleva I.V., Alexandrova G.I., Cox N.J. Genes coding for polymerase proteins are essential for attenuation of the cold-adapted A/Leningrad/134/17/57 (H2N2) influenza virus. International Congress Series 2001, 1219:955-959.